Nomura Holdings Inc Exagen Inc. Transaction History

Nomura Holdings Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$10.25 - $15.21 $3.64 Million - $5.4 Million	-355,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$13.9 - $22.0 $55,600 - $88,000	4,000 Added 1.14%	355,000 $6.2 Million
Q4 2020 Feb 16, 2021	BUY	$11.19 - $16.05 $46,998 - $67,410	4,200 Added 1.21%	351,000 $4.51 Million
Q3 2020 Nov 12, 2020	BUY	$10.56 - $16.69 $3.66 Million - $5.79 Million	346,800 New	346,800 $3.98 Million

6.41M

4.5K

400

Ticker XGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,260,400
Market Cap $94.3M
Description
Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.